Methotrexate for psoriasis. A new therapeutic schedule.
D000284:Administration, Oral; D000505:Alopecia / Q000139:chemically induced; D006801:Humans; D007273:Injections, Intramuscular; D007970:Leukopenia / Q000139:chemically induced; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D009059:Mouth Diseases / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D011379:Prognosis; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D013921:Thrombocytopenia / Q000139:chemically induced; D014456:Ulcer / Q000139:chemically induced; D014581:Urticaria / Q000139:chemically induced
D008727:Methotrexate